Another interesting stat here that was reported by Oncosil today. Overall survival with the PanCo study is 16.1 months but that data point was taken at May 2019. With almost another year and the study to be completed in June 2020, expect to see the OS to increase beyond 16.1 months.
Cheers
GW
- Forums
- ASX - By Stock
- Ann: Oncosil breakthrough device receives CE Marking approval
OSL
oncosil medical ltd
Add to My Watchlist
2.00%
!
$1.02

Another interesting stat here that was reported by Oncosil...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.02 |
Change
0.020(2.00%) |
Mkt cap ! $14.50M |
Open | High | Low | Value | Volume |
$1.00 | $1.04 | 99.5¢ | $44.55K | 44.45K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 192 | $1.03 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.04 | 6234 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 192 | 1.025 |
1 | 550 | 1.020 |
1 | 2993 | 1.000 |
1 | 3000 | 0.990 |
1 | 1000 | 0.975 |
Price($) | Vol. | No. |
---|---|---|
1.040 | 6234 | 1 |
1.050 | 25000 | 1 |
1.075 | 1879 | 1 |
1.090 | 375 | 1 |
1.190 | 3563 | 1 |
Last trade - 15.48pm 25/06/2025 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |